{"abstract":"The National Eye Institute, the National Institute on Deafness and Other Communication Disorders, and the National Heart, Lung, and Blood Institute, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an exclusive patent license to VegaVect, Inc., a start-up company spun- off from the University of Pittsburgh Medical Center Enterprises and incorporated as a C corporation under the laws of the state of Delaware, to practice the inventions covered by the patent estate listed in the SUPPLEMENTARY INFORMATION section of this notice. This is a second notice intended to apprise the public of a change in prospective licensee of the subject intellectual property rights in the stated field of use from a first notice: Prospective Grant of An Exclusive Patent License: Gene Therapy for Ocular Disease, published in the Federal Register on November 26, 2019.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2020/07/16/2020-15340.html","cfr_references":[],"citation":"85 FR 43246","comment_url":null,"comments_close_on":"2020-07-31","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Cancer Institute's Technology Transfer Center (representing the National Eye Institute and the National Heart, Lung, and Blood Institute (representing the National Institute on Deafness and Other Communication Disorders) on or before July 31, 2020 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2020-15340","effective_on":null,"end_page":43247,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2020/07/16/2020-15340.xml","html_url":"https://www.federalregister.gov/documents/2020/07/16/2020-15340/prospective-grant-of-an-exclusive-patent-license-gene-therapy-for-ocular-disease","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2020-15340?publication_date=2020-07-16","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2020-07-16/2020-15340/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":436,"last_updated":"2026-06-25 02:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-07-16/pdf/2020-15340.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-15340.pdf?1594817129","publication_date":"2020-07-16","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2020/07/16/2020-15340.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T03:53:03Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":43246,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Gene Therapy for Ocular Disease","toc_doc":"Gene Therapy for Ocular Disease","toc_subject":"Prospective Grant of Exclusive Patent License:\n","topics":[],"type":"Notice","volume":85}